rs289742
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000078.3(CETP):c.*184C>G variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.838 in 658,144 control chromosomes in the GnomAD database, including 232,789 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.80 ( 49781 hom., cov: 31)
Exomes 𝑓: 0.85 ( 183008 hom. )
Consequence
CETP
NM_000078.3 downstream_gene
NM_000078.3 downstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.177
Genes affected
CETP (HGNC:1869): (cholesteryl ester transfer protein) The protein encoded by this gene is found in plasma, where it is involved in the transfer of cholesteryl ester from high density lipoprotein (HDL) to other lipoproteins. Defects in this gene are a cause of hyperalphalipoproteinemia 1 (HALP1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 16-56983850-C-G is Benign according to our data. Variant chr16-56983850-C-G is described in ClinVar as [Benign]. Clinvar id is 369116.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.869 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CETP | NM_000078.3 | c.*184C>G | downstream_gene_variant | ENST00000200676.8 | NP_000069.2 | |||
CETP | NM_001286085.2 | c.*184C>G | downstream_gene_variant | NP_001273014.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CETP | ENST00000200676.8 | c.*184C>G | downstream_gene_variant | 1 | NM_000078.3 | ENSP00000200676.3 | ||||
CETP | ENST00000379780.6 | c.*184C>G | downstream_gene_variant | 1 | ENSP00000369106.2 | |||||
CETP | ENST00000566128.1 | c.*184C>G | downstream_gene_variant | 5 | ENSP00000456276.1 |
Frequencies
GnomAD3 genomes AF: 0.802 AC: 121907AN: 151946Hom.: 49744 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
121907
AN:
151946
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.848 AC: 429404AN: 506080Hom.: 183008 Cov.: 5 AF XY: 0.847 AC XY: 231377AN XY: 273056 show subpopulations
GnomAD4 exome
AF:
AC:
429404
AN:
506080
Hom.:
Cov.:
5
AF XY:
AC XY:
231377
AN XY:
273056
Gnomad4 AFR exome
AF:
AC:
9588
AN:
14584
Gnomad4 AMR exome
AF:
AC:
26141
AN:
32678
Gnomad4 ASJ exome
AF:
AC:
15695
AN:
17850
Gnomad4 EAS exome
AF:
AC:
21696
AN:
28978
Gnomad4 SAS exome
AF:
AC:
48364
AN:
59978
Gnomad4 FIN exome
AF:
AC:
27041
AN:
30966
Gnomad4 NFE exome
AF:
AC:
255543
AN:
290980
Gnomad4 Remaining exome
AF:
AC:
23349
AN:
27632
Heterozygous variant carriers
0
3679
7358
11036
14715
18394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1064
2128
3192
4256
5320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.802 AC: 121998AN: 152064Hom.: 49781 Cov.: 31 AF XY: 0.800 AC XY: 59465AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
121998
AN:
152064
Hom.:
Cov.:
31
AF XY:
AC XY:
59465
AN XY:
74350
Gnomad4 AFR
AF:
AC:
0.651758
AN:
0.651758
Gnomad4 AMR
AF:
AC:
0.822629
AN:
0.822629
Gnomad4 ASJ
AF:
AC:
0.881556
AN:
0.881556
Gnomad4 EAS
AF:
AC:
0.786873
AN:
0.786873
Gnomad4 SAS
AF:
AC:
0.79286
AN:
0.79286
Gnomad4 FIN
AF:
AC:
0.87021
AN:
0.87021
Gnomad4 NFE
AF:
AC:
0.875051
AN:
0.875051
Gnomad4 OTH
AF:
AC:
0.844076
AN:
0.844076
Heterozygous variant carriers
0
1174
2349
3523
4698
5872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2736
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hyperalphalipoproteinemia 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=92/8
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at